
Satellos Bioscience Inc.
Satellos Bioscience Inc. (MSLE)
WebsitePrice
Market cap
Next catalystExpected Q1 2027Forazapadin — TRAVERSE (CL-211) · Trial initiationCompany source ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Financial position
Ownership and institutions
| Status | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|